ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

SKP Skyepharma

443.00
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skyepharma LSE:SKP London Ordinary Share GB00B3BFNB64 ORD 100P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 443.00 0.00 00:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

State Street Global Advisors Form 8.3 - Vectura Group Plc (7667A)

09/06/2016 1:03pm

UK Regulatory


Skyepharma (LSE:SKP)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Skyepharma Charts.

TIDMVEC TIDMSKP

RNS Number : 7667A

State Street Global Advisors

09 June 2016

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

   1.         KEY INFORMATION 
 
 (a) Full name of discloser:                                                 State Street Global Advisors & Affiliates 
--------------------------------------------------------------------------  ------------------------------------------ 
 (b) Owner or controller of interests and short positions disclosed, if 
 different from 1(a): 
 The naming of nominee or vehicle companies is insufficient. For a trust, 
 the trustee(s), 
 settlor and beneficiaries must be named. 
--------------------------------------------------------------------------  ------------------------------------------ 
 (c) Name of offeror/offeree in relation to whose relevant securities this 
 form relates:                                                                 Vectura Group Plc 
 Use a separate form for each offeror/offeree 
--------------------------------------------------------------------------  ------------------------------------------ 
 (d) If an exempt fund manager connected with an offeror/offeree, state 
 this and specify identity 
 of offeror/offeree: 
--------------------------------------------------------------------------  ------------------------------------------ 
 (e) Date position held/dealing undertaken: 
 For an opening position disclosure, state the latest practicable date         08-June-2016 
 prior to the disclosure 
--------------------------------------------------------------------------  ------------------------------------------ 
 (f) In addition to the company in 1(c) above, is the discloser making       YES / NO / N/A 
 disclosures in respect                                                       If YES, specify which: 
 of any other party to the offer? 
 If it is a cash offer or possible cash offer, state "N/A"                    Yes - Skyepharma Plc 
--------------------------------------------------------------------------  ------------------------------------------ 
 
   2.         POSITIONS OF THE PERSON MAKING THE DISCLOSURE 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 
 Class of relevant security:                                                  0.025p ordinary 
---------------------------------------------------------------------------  ----------------------------------------- 
                                                                                   Interests          Short positions 
---------------------------------------------------------------------------  ---------------------  ------------------ 
                                                                               Number        %          Number      % 
---------------------------------------------------------------------------  ----------  ---------  -------------  --- 
 (1) Relevant securities owned and/or controlled:                             4,875,534   1.18736% 
---------------------------------------------------------------------------  ----------  ---------  -------------  --- 
 (2) Cash-settled derivatives: 
---------------------------------------------------------------------------  ----------  ---------  -------------  --- 
 (3) Stock-settled derivatives (including options) and agreements to 
 purchase/sell: 
---------------------------------------------------------------------------  ----------  ---------  -------------  --- 
 
   TOTAL:                                                                     4,875,534   1.18736% 
---------------------------------------------------------------------------  ----------  ---------  -------------  --- 
 

The change in the holding of 19,111 shares since the last disclosure for dealing 27 May 2016 is due to the transfer in of a discretionary holding.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

   (b)        Rights to subscribe for new securities (including directors' and other employee options) 
 
 Class of relevant security in relation to which subscription right exists: 
---------------------------------------------------------------------------- 
 Details, including nature of the rights concerned and relevant percentages: 
---------------------------------------------------------------------------- 
 
   3.         DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

   (a)        Purchases and sales 
 
 Class of relevant security   Purchase/sale   Number of securities   Price per unit 
---------------------------  --------------  ---------------------  --------------- 
      0.025p ordinary           Purchase             4,000             GBP 1.585 
---------------------------  --------------  ---------------------  --------------- 
 
   (b)        Cash-settled derivative transactions 
 
    Class of relevant       Product description      Nature of dealing         Number of reference      Price per unit 
         security                 e.g. CFD         e.g. opening/closing a           securities 
                                                    long/short position, 
                                                   increasing/reducing a 
                                                    long/short position 
-------------------------  --------------------  -------------------------  -------------------------  --------------- 
 
 
   (c)        Stock-settled derivative transactions (including options) 
   (i)         Writing, selling, purchasing or varying 
 
   Class of       Product        Writing,      Number of       Exercise          Type       Expiry date   Option money 
   relevant     description    purchasing,     securities      price per         e.g.                        paid/ 
   security      e.g. call       selling,       to which         unit         American,                   received per 
                   option      varying etc.      option                        European                       unit 
                                                relates                          etc. 
-------------  -------------  -------------  -------------  --------------  -------------  ------------  ------------- 
 
 
   (ii)        Exercise 
 
   Class of relevant      Product description   Exercising/ exercised    Number of securities     Exercise price per 
        security            e.g. call option           against                                           unit 
-----------------------  --------------------  -----------------------  ---------------------  ----------------------- 
 
 
   (d)        Other dealings (including subscribing for new securities) 
 
 Class of relevant security         Nature of dealing          Details   Price per unit (if applicable) 
                               e.g. subscription, conversion 
---------------------------  -------------------------------  --------  ------------------------------- 
 
 
   4.         OTHER INFORMATION 
   (a)        Indemnity and other dealing arrangements 
 
 Details of any indemnity or option arrangement, or any agreement or understanding, formal 
  or informal, relating to relevant securities which may be an inducement to deal or refrain 
  from dealing entered into by the person making the disclosure and any party to the offer or 
  any person acting in concert with a party to the offer: 
  Irrevocable commitments and letters of intent should not be included. If there are no such 
  agreements, arrangements or understandings, state "none" 
--------------------------------------------------------------------------------------------- 
 
   None 
--------------------------------------------------------------------------------------------- 
 
   (b)        Agreements, arrangements or understandings relating to options or derivatives 
 
 Details of any agreement, arrangement or understanding, formal or informal, between the person 
  making the disclosure and any other person relating to: 
  (i) the voting rights of any relevant securities under any option; or 
  (ii) the voting rights or future acquisition or disposal of any relevant securities to which 
  any derivative is referenced: 
  If there are no such agreements, arrangements or understandings, state "none" 
----------------------------------------------------------------------------------------------- 
 
   None 
----------------------------------------------------------------------------------------------- 
 
   (c)        Attachments 
 
 Is a Supplemental Form 8 (Open Positions) attached?            No 
----------------------------------------------------  ------------ 
 
 
 Date of disclosure:    09-June-2016 
---------------------  -------------- 
 Contact name:          Chetan Shah 
---------------------  -------------- 
 Telephone number:      020 3395 6564 
---------------------  -------------- 
 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RETGMGGVZLFGVZM

(END) Dow Jones Newswires

June 09, 2016 08:03 ET (12:03 GMT)

1 Year Skyepharma Chart

1 Year Skyepharma Chart

1 Month Skyepharma Chart

1 Month Skyepharma Chart

Your Recent History

Delayed Upgrade Clock